September 26, 2014 — Biotronik announced that the results of the EDUCAT study support a link between patient comprehension and clinical acceptance regarding remote monitoring. The study underscores the benefits of Biotronik Home Monitoring, showing that deepening patients’ knowledge of remote monitoring technology increases their understanding of its benefits.
September 26, 2014 — In response to new science showing that complete revascularization of all significantly blocked arteries leads to better outcomes in some heart attack patients, the American College of Cardiology (ACC) has withdrawn its Choosing Wisely recommendation that patients and caregivers examine whether this practice is truly necessary.
AtriCure Inc. announced the introduction of the AtriClip Flex, a new device with a more flexible aluminum shaft that allows surgeons to better maneuver within a patient’s particular anatomy.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The first randomized trial to examine serial optical coherence tomography (OCT) in primary percutaneous coronary intervention (PCI) was reported at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium last week. The trial showed similar outcomes in to a control group that did not use OCT. The nine-month follow up data showed significantly smaller area stenosis and a trend toward fewer uncovered struts in the OCT guided group.
St. Jude Medical Inc. announced CE mark approval of updated labeling for its Tendril STS and IsoFlex Optim pacing leads, allowing existing and future patients with the devices access to magnetic resonance imaging (MRI) scans.
A new study found that intravascular ultrasound (IVUS)-guided intervention in patients with chronic total occlusion (CTO) could improve outcomes compared to a conventional angiography-guided approach during percutaneous coronary intervention (PCI). The IVUS-CTO study is the first randomized trial to examine the clinical impact of IVUS guidance for CTO intervention.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results and better late clinical outcomes. Findings were reported at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
A first-of-its kind study comparing the safety and efficacy of biodegradable polymer sirolimus-eluting stents (BP-SES) to durable polymer sirolimus-eluting stents (DP-SES) found that the biodegradable stents were non-inferior to the durable polymer stents after one year of follow-up.
The first large prospective study to examine the effectiveness of laser atherectomy in the treatment of femoropopliteal in-stent restenosis (ISR) found that the procedure combined with percutaneous transluminal angioplasty (PTA) was more effective than PTA alone. Findings of the EXCITE ISR trial were reported at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
FEI released RemoteViz for Open Inventor, a software development framework for interactive remote 2-D and 3-D visualization.
Svelte Medical Systems reported that its drug-eluting coronary stent Integrated Delivery System (IDS) for percutaneous coronary intervention (PCI) met all DIRECT II study six-month angiographic and clinical endpoints.
Mallinckrodt announced the U.S. launch of the OptiSync data management system as a new technology in its Global Medical Imaging segment.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
DAIC Editor, Dave Fornell, interviews Jim Hermiller, M.D., FACC, director of interventional cardiology, St. Vincent ...
John Stevens, chairman and CEO of HeartFlow, explains his company's computed tomography (CT)-based fractional flow ...
September 24, 2014 — An initiative to improve the use of cardiac telemetry at Christiana Care Health System enhanced the value of care to patients and resulted in savings of $4.8 million, Christiana Care researchers reported in JAMA Internal Medicine, published online Sept. 22.